Back to results
US 2023/0416232 A1Published application
Pyrimidine compounds, compositions, and medicinal applications thereof
AssigneeBlueprint Medicines Corporation
InventorsGurulingappa Hallur, Naveena Madhyastha, Michael Rajesh Stephen, Bruce Roth, Anjali Pandey, Tracy Saxton
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a class of pyrimidine compounds, their stereoisomers, tautomers, pharmaceutically acceptable salts, stereoisomers, solvates, and hydrates thereof. The present disclosure also relates to a process of preparation of these pyrimidine compounds, pharmaceutical compositions containing them, and medicinal applications thereof.
Claims92
A compound of Formula I:
- or a pharmaceutically acceptable salt or stereoisomer thereof, wherein:
- X is —NH— or —O—;
- R1 is —(C(R4)2)nR5, wherein R5 is substituted with 2 or 3 R5′;
- n is 0, 1, 2, or 3;
- each R4 is independently hydrogen, alkyl, halo, haloalkyl, hydroxy, alkoxy, or heteroalkyl;
- R5 is C4-10cycloalkyl, aryl, or heteroaryl;
- each R5′ is independently deuterium, aryl, heteroaryl, alkyl, C3-C6 cycloalkyl, 3-8 membered heterocycloalkyl, oxo, halo, heteroalkyl, haloalkyl, cyano, hydroxy, amino, —NH2, —NHR6, —N(CH3)R6, —N(R6)2, —C(═O)NH2, —C(═O)NHR6, —C(═O)N(R6)2, —NR6C(═O)R6, —NHC(═O)R6, —S(═O)2alkyl, —S(═O)2aryl, —S(═O)2NH2, —S(═O)2NHR6, —S(═O)2N(R6)2, —S(═O)2heteroaryl, alkoxy, or haloalkoxy;
- or
- two adjacent R5′ groups come together to form a 5- to 10-membered heterocycle, wherein the 5- to 10-membered heterocycle is unsubstituted or substituted with alkyl;
- each R6 is independently alkyl, aminoalkyl, cycloalkyl, aryl, or heteroaryl;
- R2 is aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, wherein the aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is substituted with at least one R7 and 0, 1, or 2 R8;
- each R7 is independently
- Y is —C(═O)—, —S(═O)—, or —S(═O)2—;
- R9, R9′, and R9″ are independently hydrogen, deuterium, halo, alkyl, haloalkyl, cycloalkyl, heteroalkyl, or (alkyl)heterocycloalkyl;
- R10 is hydrogen, alkyl, haloalkyl, or cycloalkyl;
- each R8 is independently aryl, heteroaryl, alkyl, cycloalkyl, heterocycloalkyl, halo, heteroalkyl, haloalkyl, cyano, hydroxy, amino, —N(R11)2, —S(═O)2alkyl, —S(═O)2aryl, —S(═O)2heteroaryl, or alkoxy;
- each R11 is independently alkyl, cycloalkyl, aryl, or heteroaryl;
- R3 is heteroaryl substituted with 0, 1, 2, or 3 R12;
- each R12 is independently aryl, heteroaryl, alkyl, heteroalkyl, haloalkyl, halo, cyano, alkoxy, heterocycloalkyl, —N(R13)2, —S(═O)2NH2, —S(═O)2alkyl, —S(═O)2aryl, —S(═O)2heteroaryl, or cycloalkyl, wherein the aryl, heteroaryl, heterocycloalkyl, or cycloalkyl are each independently unsubstituted or substituted with 0, 1, or 2 R14;
- each R13 is independently hydrogen, alkyl, cycloalkyl, aryl, or heteroaryl;
- each R14 is independently deuterium, aryl, heteroaryl, alkyl, cycloalkyl, heterocycloalkyl, halo, heteroalkyl, haloalkyl, cyano, hydroxy, amino, —N(R11)2, —S(═O)2alkyl, —S(═O)2aryl, —S(═O)2heteroaryl, or alkoxy;
- and
- each R15 is independently alkyl, cycloalkyl, aryl, or heteroaryl.
20 more elements
Dependencies are inferred from the claim text.